Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 27,439 | 38,282 | 45,891 | 32,811 | 21,303 |
| Gross Profit | 27,439 | 38,282 | 45,891 | 32,811 | 21,303 |
| Operating Expenses | 90,760 | 103,164 | 77,759 | 61,043 | 45,357 |
| Operating Income | -63,321 | -64,882 | -31,868 | -28,232 | -24,054 |
| Other Income | 449 | 1,510 | 1,944 | 1,414 | 3,322 |
| Pre-tax Income | -62,872 | -63,372 | -29,924 | -26,818 | -20,732 |
| Net Income Continuous | -62,872 | -63,374 | -29,924 | -26,818 | -20,732 |
| Net Income | $-62,872 | $-63,374 | $-29,924 | $-26,818 | $-20,732 |
| EPS Basic Total Ops | -0.60 | -0.61 | -0.29 | -0.26 | -0.20 |
| EPS Basic Continuous Ops | -0.60 | -0.61 | -0.29 | -0.26 | -0.20 |
| EPS Diluted Total Ops | -0.60 | -0.61 | -0.29 | -0.26 | -0.20 |
| EPS Diluted Continuous Ops | -0.60 | -0.61 | -0.29 | -0.26 | -0.20 |
| EBITDA(a) | $-61,028 | $-62,254 | $-29,922 | $-25,819 | $-22,508 |